Global outsourcing of pharma R&D/testing, tightening food-safety and export - compliance norms, and India's cost/talent advantage drive multi - year demand for accredited CRTO capacity. Unlike acquisition - led peers, Vimta has grown organically adding ~200,000 sq .ft. at its Genome Valley Life Sciences campus (~INR 100 Cr, FY 25- 26) and doubling EMI/EMC chamber capacity for defence - electronics demand.